U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drugs@FDA

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 209506
Company: TARO
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
DAPSONE DAPSONE 5% GEL;TOPICAL Prescription AB No No
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
10/16/2017 ORIG-1 Approval STANDARD Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209506Orig1s000lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/209506Orig1s000ltr.pdf
Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
09/27/2019 SUPPL-1 Labeling-Package Insert

Label is not available on this site.

Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels,
Patient Package Insert
Note Url
10/16/2017 ORIG-1 Approval Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/209506Orig1s000lbl.pdf

DAPSONE

GEL;TOPICAL; 5%
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
ACZONE DAPSONE 5% GEL;TOPICAL Prescription Yes AB 021794 ABBVIE
DAPSONE DAPSONE 5% GEL;TOPICAL Prescription No AB 209890 AMNEAL
DAPSONE DAPSONE 5% GEL;TOPICAL Prescription No AB 210178 COSETTE
DAPSONE DAPSONE 5% GEL;TOPICAL Prescription No AB 212383 ENCUBE
DAPSONE DAPSONE 5% GEL;TOPICAL Prescription No AB 209506 TARO
DAPSONE DAPSONE 5% GEL;TOPICAL Prescription No AB 213907 TRUPHARMA
Back to Top